Denali Therapeutics Inc

Company Snapshot
161 Oyster Point Boulevard
South San Francisco, CA 94080
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 427
https://www.denalitherapeutics.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
Operating Income
$62,718,000
($295,751,000)
($340,744,000)
Net Income
$71,136,000
($290,581,000)
($325,991,000)
2020
Gross Profit
Operating Income
$62,718,000
Net Income
$71,136,000
2021
Gross Profit
Operating Income
($295,751,000)
Net Income
($290,581,000)
2022
Gross Profit
Operating Income
($340,744,000)
Net Income
($325,991,000)
The above data on Denali Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Ryan Watts
Director, President and Chief Executive Officer
$1,032,000
$8,240,488
$12,200
$9,284,688
Ryan Watts
$9,284,688
Director, President and Chief Executive Officer
Alexander Schuth
Chief Financial Officer, Chief Operating Officer and Secretary
$725,000
$4,954,852
$12,200
$5,692,052
Alexander Schuth
$5,692,052
Chief Financial Officer, Chief Operating Officer and Secretary
Carole Ho
Chief Medical Officer and Head of Development
$725,000
$4,954,852
$12,200
$5,692,052
Carole Ho
$5,692,052
Chief Medical Officer and Head of Development
Steve Krognes
Director
$197,088
$4,113,127
$6,683
$4,316,898
Steve Krognes
$4,316,898
Director
Erik Harris
Independent Director
$49,839
$653,472
$0
$703,311
Erik Harris
$703,311
Independent Director
Denali Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us